There's never a shortage of losers in the stock market.
Let's take a closer look at five of this past week's biggest sinkers.
|Feb. 24||Weekly Loss||My Watchlist|
Yingli Green Energy
GTx was last week's biggest loser, shedding 41% of its value after regulators suspended studies of its once-promising treatment for advanced prostate cancer. GTx clearly had a lot riding on Capesaris.
US Airways led its peers the wrong way down the runway. Investors sold off air carriers as oil prices hit a nine-month high.
Celldex shares took a hit after the biotech upstart completed a secondary offering. Celldex sold 10.5 million shares at $3.85 apiece. That was a healthy discount to where the stock was when the offering was announced, though it happens to be exactly where it closed out the week.
It was a bad week for solar energy stocks, and Yingli Green Energy was one of the many companies in this volatile specialty to post a double-digit percentage decline.
GrafTech slipped after posting uninspiring quarterly results. The electrode maker's revenue of $348 million clocked in well short of the $363 million that Wall Street was targeting. GrafTech's hoping to raise prices to offset declining sales volume, but that's a risky strategy.
Ready for a bounce
It was a rough week for these five stocks. If you want to shake yesterday's losers and ride tomorrow's winners, a new special report reveals Motley Fool's top stock for 2012. It's free, but only for a limited time, so check it out now.